Skip to main content

Non-Small Cell Lung Cancer Topic Center

Interactive Features

conference coverage


Conference Coverage
04/01/2025
Grace Taylor, MS, MA
New research shows that polygenic risk scores may enhance the prediction of non–small cell lung cancer (NSCLC) risk by highlighting key genetic mutations.
New research shows that polygenic risk scores may enhance the prediction of non–small cell lung cancer (NSCLC) risk by highlighting key genetic mutations.
New research shows that...
04/01/2025
First Report Managed Care
Alexander Whitley, MD, PhD, FACRO
Conference Coverage
10/23/2024
Alexander Whitley, MD, PhD, FACRO
Discover the importance of multidisciplinary team care coordination in managing early-stage NSCLC from an AVAHO 2024 session speaker.
Discover the importance of multidisciplinary team care coordination in managing early-stage NSCLC from an AVAHO 2024 session speaker.
Discover the importance of...
10/23/2024
First Report Managed Care
Conference Coverage
06/01/2023
Grace Taylor, MS, MA
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of myeloid cells, including monocytes and eosinophilis, as prognostic biomarkers for patients with non-small cell lung cancer (NSCLC) who have been treated with cemiplimab.
Researchers evaluated the use of...
06/01/2023
First Report Managed Care
Conference Coverage
03/21/2023
Maria Asimopoulos
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.
Investigators compared the...
03/21/2023
First Report Managed Care